MBRX Moleculin Biotech Inc
Company Analysis
Latest News
🟢 Moleculin Biotech is trading 12.26% up today
Moleculin Biotech is trading 12.26% up now at $0.80, based on the provided live price context; no clear company-specific catalyst has been identified for...
🟢 Moleculin Biotech is trading 8.5% up; no clear catalyst identified
Moleculin Biotech is trading 8.5% up at $0.77, with no clear company-specific catalyst identified for September 8, 2026. - Recent coverage focuses on earlier...
🟢 Moleculin Biotech is trading 6.57% up today with no confirmed company-specific catalyst identified
Moleculin Biotech is trading 6.57% higher at $0.72, with no confirmed company-specific catalyst identified for September 4, 2026. - Updates focus on the...
🟢 Moleculin Biotech is trading 7.92% up in pre-market — no confirmed catalyst identified
Moleculin Biotech is trading 7.92% up at $0.73 in pre-market with no confirmed company-specific catalyst identified for September 4, 2026. - Recent updates...
🔴 Moleculin Biotech is trading 6.21% down today with no confirmed catalyst identified
Moleculin Biotech is trading at $0.65, down 6.21%, with no confirmed company-specific catalyst identified. - No new company-specific announcement dated...
🟢 Moleculin Biotech is trading 7.38% up today as XBI gains 2.75%
Moleculin Biotech is trading 7.38% up at $0.70, supported primarily by biotech-sector strength, with XBI up 2.75% during regular trading. - No new...
Moleculin Biotech Target Slashed 86% to $3, Buy Rating Maintained
HC Wainwright & Co. reiterated its Buy rating for Moleculin Biotech. The firm lowered its price target from $22.00 to $3.00. This adjustment represents an...
🟢 Moleculin Biotech is trading 6.03% up in after-hours trading with no clear catalyst identified
Moleculin Biotech is trading 6.03% up at $0.69 after an after-hours rebound with no clear company-specific catalyst. - It closed August 28, 2026, at $0.65...
🔴 Moleculin Biotech falls 5.2% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🔴 Moleculin Biotech is trading 5.6% down today in pre-market without a clear negative catalyst
Moleculin Biotech is trading 5.6% down at $0.65 in pre-market, with no clear negative company-specific catalyst identified. - Shares gained 14.78% to $0.69 on...
🟢 Moleculin Biotech is trading 6.26% up in pre-market after positive interim MIRACLE trial data presentation
Moleculin Biotech is trading 6.26% up in pre-market at $0.73 after announcing its August 27, 2026 participation in Virtual Investor’s “Why Now” on-demand...
🟢 Moleculin Biotech is trading 15.37% up today amid risk-on sentiment fueled by Nvidia's strong results
Moleculin Biotech is trading 15.37% up at $0.69, moving higher alongside a risk-on market backdrop fueled by Nvidia’s strong results and outlook. - The Nasdaq...
🟢 Moleculin Biotech is trading 8.35% up today as Nvidia’s strong results lift broader risk appetite
Moleculin Biotech is trading 8.35% up at $0.65 after opening-market strength on August 27, 2026, amid broader risk appetite following Nvidia’s strong results...
🟢 Moleculin Biotech is trading 5.2% up today amid broad biotech-sector risk-on sentiment
Moleculin Biotech is trading 5.2% up at $0.64 after opening-market strength on August 26, 2026, amid a broad biotech-sector rally. - No company-specific...
🟢 Moleculin Biotech is trading 6.38% up in pre-market — no company-specific catalyst identified
Moleculin Biotech is trading 6.38% up in pre-market at $0.65, after rising from the August 25 close of $0.61; no new company-specific announcement or overnight...
🟢 Moleculin Biotech rises 5.0% — Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, represented by the XBI ETF, is...
🟢 Moleculin Biotech is trading 8.27% up in pre-market after Zacks’ #2 Buy upgrade; cause unclear
Moleculin Biotech is trading at $0.66 (+8.27%) in pre-market, with no August 25 company announcement, filing, or major catalyst identified. - Zacks upgraded...
🟢 Moleculin Biotech is trading 6.24% up in pre-market with no confirmed catalyst identified
Moleculin Biotech is trading 6.24% up in pre-market at $0.63 after no confirmed company-specific announcement was identified for August 24, 2026. - The latest...
🟢 Moleculin Biotech is trading 5% up today — No confirmed company-specific catalyst
Moleculin Biotech is trading 5.01% up at $0.62, based on the provided live price at 9:57 a.m. EST on August 21, 2026; no company-specific announcement dated...
🟢 Moleculin Biotech is trading 6.67% up in pre-market — no explicit explanation identified
Moleculin Biotech is trading 6.67% up in pre-market at $0.63; no explicit explanation for the move was identified. - No new company-specific announcement...